3Daniels GL, Cartron JP, Fletcher A, et al. International society of blood transfusion committee on terminology for red cell surface antigens: Vancouver report[J]. Vox Sang, 2003, 84(3) : 244 -247.
4Marion ER, Ragnhid O, Marsh WL. The clinical significance of alloantibodies of blood group system [ J ]. Semin Hematol, 2000, 37 (2) : 197 -203.
5Lin M. Blood groups and transfusion medicine in Taiwan[J]. J Formos Med Assoc, 1997, 96(12) : 933 -942.
6Jeffrey L, Winters AA, Pineda LD, et al. RBC alloantibody specificity and antigen potency in olmsted county, minnesota[ J ]. Transfusion, 2001,41(11) : 1413 -1420.
7Ameen R, Al-Eyaadi O, Al-Shemmari S, et al. Frequency of red blood cell alloantibody in Kuwaiti population [ J ]. Med Princ Pract, 2005, 14(4) : 230 -234.
8Kumpel BM. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D[J]. Vox Sang, 1997, 72( 1 ) : 45 -51.
